Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...
Researchers have produced a review of chromatography media and purification processes for handling complex and super-large ...
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya vaccine is expected to launch in key European markets in ...
Harnessing the ultrasonic vibrations of tiny viral particles is leading researchers down new paths of discovery.
10d
IFLScience on MSNNanoparticle Vaccine Could Protect Against Future COVID-19 Variants – Plus Other CoronavirusesA newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...
Elad Harel is used to shining a light on the mysteries of the natural world. Working at the cutting-edge of ultrafast ...
We now know that most proteins diffuse ... fold decrease in particle transport rate, due to charge-facilitated binding to mucin fibres. This approach mimics the properties of virus particles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results